About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lupus Clinical Trials | 1,277 Studies Recruiting

Clinical TrialsLupus

Lupus Clinical Trials

Browse 1,277 clinical trials for lupus. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 961-980 of 1,277 trials

UnknownAutophagy in Systemic Lupus ErythematosusSystemic lupus erythematosus is systemic autoimmune disease characterized by a wide range of clinical manifestations, from skin and mucosal lesions to severe injuries in the…NCT03583853 CompletedGSK1550188 A 52 Week Study of Belimumab Versus Placebo in the Treatment of Subjects With Systemic Lupus Erythematosus (SLE) Located in Northeast AsiaThe purpose of this study is to evaluate the efficacy and safety of belimumab in addition to standard therapy compared to placebo in subjects in Northeast Asia with systemic lupus…NCT01345253·Hefei, Anhui and 46 others

Related Searches

sletrials systemic lupustrials

Data from ClinicalTrials.govTerms

CompletedAnti-ficolin-2 Autoantibodies in Lupus NephritisSystemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by the production of multiple autoantibodies.NCT03063281

Active not recruitingA Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus ErythematosusThe goal of this clinical trial is to see how well cenerimod reduces symptoms of Systemic Lupus Erythematous in adult patients with moderate to severe symptoms.NCT05672576·Tucson, Arizona and 146 others

CompletedDehydroepiandrosterone (DHEA) in Systemic Lupus Erythematosus (SLE) for Coronary Artery Disease (CAD) PreventionThe purpose of this study is to evaluate the effect of DHEA on endothelial dysfunction in patients with systemic lupus by measuring: 1. changes in brachial artery flow-mediated…NCT00189124·Ann Arbor, Michigan

Recruiting2-HOBA in Systemic Lupus ErythematosusThis is a phase II randomized, placebo-controlled, double-blind, cross-over study to determine the effect of isolevuglandin (IsoLG) scavenging by 2-HOBA on blood pressure and…NCT07225543·Nashville, Tennessee

CompletedA Study of KZR-616 in Patients With SLE With and Without Lupus NephritisThis was a Phase 1b/2, multi-center study in which patients received KZR-616, administered as a subcutaneous (SC) injection weekly for 13 weeks (Phase 1b) or 24 weeks (Phase 2).NCT03393013·Los Angeles, California and 35 others

CompletedPeer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic ConditionsThe purpose of this study is to test the efficacy of a peer support coaching intervention to improve activated chronic illness self-management versus an attention control group in…NCT03938324·Durham, North Carolina

WithdrawnStudy to Evaluate Safety, Tolerability and Pharmacodynamics of KP104 in Participants With Thrombotic Microangiopathy Secondary to Systemic Lupus ErythematosusThis study will evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and efficacy of KP104 in participants with systemic lupus erythematosus…NCT05504187

CompletedAtherosclerosis in Rheumatoid Arthritis and Lupus: Restoring Cholesterol BalanceHypothesis: SLE and RA increase risk of myocardial infarction (MI, heart attack).NCT01180361·Mineola, New York

RecruitingA Study to Assess the Safety and PK/PD of LBL-047 in Healthy Adults and Patients With Systemic Lupus ErythematosusA Double-blind, Randomized, Placebo-controlled, Dose-escalation Phase I Study to Assess the Safety and PK/PD of LBL-047 Subcutaneous Injection in Healthy Adults and Patients with…NCT07323173·Bengbu, Anhui and 11 others

CompletedMulticenter Study Assessing the Efficacy & Safety of Hydroxychloroquine Sulfate in Patients With Systemic Lupus Erythematosus or Cutaneous Lupus Erythematosus With Active Lupus Erythematosus Specific Skin LesionPrimary Objective: \- To investigate the efficacy on skin manifestation of 16 weeks treatment of once daily regimen of hydroxychloroquine sulphate (HCQ) in patients with…NCT01551069·Bunkyō City and 21 others

Not yet recruitingNon Invasive Assessment of Subclinical Atherosclerosis and Cardiovascular Risk Using TYG Index in Lupus NephritisSystemic lupus erythematosus (SLE) is a chronic, multisystem autoimmune disease characterized by loss of immune tolerance, autoantibody production, immune complex deposition, and…NCT07719322·Asyut, Assuit

UnknownEfficacy and Safety of Tamibarotene(AM80) for Lupus NephritisAn open-label study to evaluate the efficacy and safety of orally administered Tamibarotene to patients of Lupus NephritisNCT01226147·Osaka

CompletedIn Vitro Effect Study of Interleukin-2 Muteins on Regulatory T Cells of Patients With Different Autoimmune, Allo-immune or Inflammatory DiseasesInterleukin 2 (IL-2) is a critical cytokine for the survival and function of regulatory T cells (LTreg). This cytokine has a dual role in the immune system.NCT05544448·Créteil, Île-de-France Region

UnknownDelivery of Enhance Fitness TrialArthritis is a common condition in the United States, and a leading cause of pain and disability.NCT05275348·Seattle, Washington

CompletedEffects of Treatment of Chronic Stress in Patients With Lupus* Daily stress can worsens the clinical course of lupus. * Objective: to determine the efficacy of the stress management therapy in a group of patients with lupus.NCT00483613·Granada, Spain/Granada

Not yet recruitingEffectiveness of Resonance Frequency Breathing Exercises in Patients With Systemic Lupus Erythematosus and Central SensitizationSystemic Lupus Erythematosus (SLE) is a chronic autoimmune disease characterized by systemic inflammation, fatigue, central sensitization, and chronic pain.NCT07868289·Istanbul, Istanbul

Not yet recruitingLUpus Eritematoso Sistemico NETwork and RegistryThe LUNET Registry is intended to serve as a comprehensive primary data source, capturing real-world longitudinal clinical information, and the heterogeneity of patient…NCT07175610·Ancona and 15 others

RecruitingTesting of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint InhibitorsThis study learn how easily patients can use an educational tool that will be created for patients with melanoma and pre-existing autoimmune diseases who receive or will receive…NCT04751396·Houston, Texas

PreviousPage 49 of 64Next